2024-03-29T01:44:02Z
https://niigata-u.repo.nii.ac.jp/oai
oai:niigata-u.repo.nii.ac.jp:00016859
2022-12-15T03:48:20Z
453:456
471:537:538:1112
1)血液浄化療法の進歩(シンポジウム 人工臓器はここまで進んだ, 第522回新潟医学会)
1)血液浄化療法の進歩(シンポジウム 人工臓器はここまで進んだ, 第522回新潟医学会)
Progression of Blood Purification Therapy (Present Status of Artificial Organs)
青池, 郁夫
荒川, 正昭
on-Line HF/HDF
Acetate Free Biofiltration
β2-M adsorption
Endotoxin adsorption
オンライン式血液濾過/濾過透析
バイオフィルトレーション
β2-ミクログロブリソ吸着
エンドトキシン吸着
Hemodialysis is the most widely used mode of treatment for chronic renal failure (CRF) patients. Recent technological developments of devices and evolution of water purification procedure brought many advantages to the blood purification therapy. Especially, on-line preparation method for substitution fluid could remove massive exchangeable fluid by hemofiltration (HF) and hemodialfiltration (HDF). Furthermore, the direct blood perfusion device which can adsorb serum β2-microglobulin was developed. These treatments are quite possible to improve the prognosis of dialysis-related amyloidosis (DRA). New devices are used for the treatment of not only CRF but also acute renal failure (ARF) and/or multiple organ dysfunction Syndrome (MODS). Infectious disease and endotoxin shock are frequently seen in MODS. In these cases, endotoxin adsorption column which contains polymixine B is applied for treatment of endotoxicemia. This paper will present recent technical developments of CRF treatment and, in addition, acute blood purification for critically ill patients.
新潟医学会
1998-01
jpn
departmental bulletin paper
http://hdl.handle.net/10191/45693
https://niigata-u.repo.nii.ac.jp/records/16859
AN00182415
00290440
新潟医学会雑誌
新潟医学会雑誌
112
1
1
5
https://niigata-u.repo.nii.ac.jp/record/16859/files/112(1)_1-5.pdf
application/pdf
793.5 kB
2019-08-07